FDA Drug Application (206073) for GLYXAMBI by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number206073
Product Number001
FormTABLET;ORAL
Dosage10MG;5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameGLYXAMBI
Active IngredientEMPAGLIFLOZIN; LINAGLIPTIN

Active IngredientCount
List of drugs with Active Ingredient EMPAGLIFLOZIN3
List of drugs with Active Ingredient LINAGLIPTIN4


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM